An Internet-Based Smokeless Tobacco Cessation Program for Teens

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Smokeless Tobacco Use

See also
Status	Clinical Trial	Phase
Completed	`NCT00939029` - Highdose Nicotine Patch Therapy for Smokeless Tobacco Use	Phase 2/Phase 3
Completed	`NCT00392379` - Nicotine Lozenges for Treatment of Smokeless Tobacco Addiction	Phase 3
Completed	`NCT01067586` - Novel Determinants and Measures of Smokeless Tobacco Use: Study 1
Completed	`NCT00888459` - A Pilot Study Evaluating Nicotine Lozenges and Self Help	Phase 2

See also

Status

Clinical Trial

Phase

Completed

NCT00939029 - Highdose Nicotine Patch Therapy for Smokeless Tobacco Use

Phase 2/Phase 3

Completed

NCT00392379 - Nicotine Lozenges for Treatment of Smokeless Tobacco Addiction

Phase 3

Completed

NCT01067586 - Novel Determinants and Measures of Smokeless Tobacco Use: Study 1

Completed

NCT00888459 - A Pilot Study Evaluating Nicotine Lozenges and Self Help

Phase 2

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT00680615
Study type	Interventional
Source	Oregon Research Institute
Contact
Status	Completed
Phase	Phase 2
Start date	May 2008
Completion date	March 2012

An Internet-Based Smokeless Tobacco Cessation Program for Teens

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms